A market leader within the in vitro diagnostics industry, Randox provides high quality, innovative solutions to make diagnostic testing faster, with higher accuracy and reliability. Founded in 1982 in Crumlin, Co. Antrim, the company manufactures 3.2 billion diagnostic tests per year and approximately 4% of the total usage of tests in the world.
Committed to assist healthcare on a global scale, this leading manufacturer offers an extensive product portfolio for clinical laboratories that includes clinical chemistry reagents, clinical chemistry analyzers, and quality control material.
Its versatile range of clinical chemistry analyzers is collectively known as the RX series. The extensive RX series test menu guarantees flexibility and consolidation through high quality routine and specialized testing. These tests include routine chemistries, specific proteins, lipids, therapeutic drugs, drugs-of-abuse, antioxidants, and diabetes testing.
With its focus on research and development activity, Randox is also an OEM manufacturer for some of the world’s largest diagnostic companies.
The CO2 TOTAL (Liquid) Second Generation Reagent offered by the company is intended for the quantitative in vitro determination of carbon dioxide in serum and plasma and is suitable for use on the RX series of instruments. The RX Daytona plus is a fully automated, random access, benchtop analyser. Its ability to run emergency samples ensures optimum efficiency in the laboratory and rapid turnaround of STAT samples.
Other quality lab products including reagents and controls from the company include – Tri-Level Cardiac Control, Liquid Cardiac Control Level 2, 3 x 3mL, Human Liquid Precision Multisera Controls, Level 3, 20 x 5mL, and Albumin Reagent.